首页> 外文OA文献 >Noncompliance and Cessation of Dual Antiplatelet Therapy After Coronary Stenting Looking at the Speck Rather Than Noticing the Log?∗

【2h】

Noncompliance and Cessation of Dual Antiplatelet Therapy After Coronary Stenting Looking at the Speck Rather Than Noticing the Log?∗

机译：冠状动脉支架术后双重抗血小板治疗的不依从性和戒除是从斑点上看，而不是从原木上看？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Biondi-Zoccai Giuseppe; Frati Giacomo; Abbate Antonio;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Noncompliance and Cessation of Dual Antiplatelet Therapy After Coronary Stenting Looking at the Speck Rather Than Noticing the Log? [J] . Biondi-Zoccai Giuseppe, Frati Giacomo, Abbate Antonio JACC. Cardiovascular interventions . 2015,第3期

机译：冠状动脉支架置入术后双重抗血小板治疗的不依从性和戒除是从斑点上看，而不是从日志上看？
2. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. [J] . Mauri L, Kereiakes DJ, Normand SL, The American heart journal . 2010,第6期

机译：双重抗血小板治疗研究的原理和设计，这是一项前瞻性，多中心，随机，双盲试验，旨在评估经药物洗脱支架或裸露经皮冠状动脉介入治疗的受试者12个月与30个月双重抗血小板治疗的有效性和安全性金属支架置入术治疗冠状动脉病变。
3. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial. [J] . Park SW, Kim YH, Yun SC, Journal of the American College of Cardiology . 2011,第11期

机译：三重抗血小板治疗与双重抗血小板治疗减少长期冠状动脉病变药物洗脱支架植入后再狭窄的随机，双盲，多中心比较研究：DECLARE-LONG II（药物洗脱支架置入，西洛他唑治疗后减少晚期）的结果长期冠状动脉病变患者的再狭窄）试验。
4. Ribozyme gene therapy to prevent restenosis after coronary angioplasty: stent regulation of the microenvironment [C] . N. Eigler, K. Park, R. Makkar, International symposium on controlled release of bioactive materials;Consumer and diversified products conference . 1998

机译：核酶基因疗法可预防冠状动脉成形术后的再狭窄：微环境的支架调节
5. Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group open-label blinded-endpoint superiority multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting [O] . Lisa Riesinger, Claudia Strobl, David M. Leistner, 2021

机译：Apixaban与苯procoumon：口服抗凝加抗血小板治疗急性冠状动脉综合征和心房颤动的患者（方法-ACS-AF）：理论和设计前瞻性随机平行开放标签盲 - 终点优势多中心试验对心房颤动患者的三重治疗与双重治疗和急性冠状动脉综合征接受冠状动脉抵抗
6. Noncompliance and cessation of dual antiplatelet therapy after coronary stenting: looking at the speck rather than noticing the log? [O] . G. Biondi-Zoccai, G. Frati, A. Abbate. 2015

机译：冠状动脉支架置入术后双重抗血小板治疗的不依从性和停止行为：观察斑点而不是注意日志？

Noncompliance and Cessation of Dual Antiplatelet Therapy After Coronary Stenting Looking at the Speck Rather Than Noticing the Log?∗

著录项

引文网络

相似文献

相关主题

期刊订阅